Nigeria’s Amazigo to Win Prestigious Prince Mahidol Award
The popular saying that goldfish have no hiding
place aptly summaries the story of Dr. Uche Amazigo, Nigeria’s renowned
scientist, former senior lecturer and public health specialist who has
continued to win laurels for her outstanding contribution to finding
solutions for numerous global public health problems.
The latest feather to Dr. Amazigo’s rich hat is the prestigious
Prince Mahidol Award 2012, for playing a crucial role behind the
successful Community-Directed Treatment with Ivermectin (CDTI) strategy
used by the World Health Organization (WHO) for the control of
Onchocerciasis.
.
Onchocerciasis or River blindness is a major cause of blindness and
skin disease with unrelenting itching, in many African countries. The
success of the CDTI approach, results from linking research and
management strategies and empowering communities to fully participate
and assume ownership of their health care delivery system.
As a leading figure in the introduction and application of CDTI,
which is also known as the Community-Directed Intervention (CDI)
Strategy in the treatment and control of diseases, Dr. Amazigo’s
research in 1990 provided the scientific basis for the establishment of
the WHO’s African Programme for Onchocerciasis Control (WHO/APOC), with
headquarters in Burkina Faso. This unique programme has always been run
by Africans for Africans, the disease having plagued the continent for
centuries.
Dr. Amazigo, described as a scientist with a large heart for the
poor, is instrumental in the success in bringing the disease under
control and in strengthening community health systems in 140,000
communities in 16 of the 19 countries covered by WHO/APOC.
Although community-directed treatment was introduced as a strategy
to increase coverage and access to a drug for river blindness control,
the strategy has had tremendous impacts on the control of other diseases
and essential healthcare services in Africa. It is estimated that this
strategy, which she defended and devoted almost two decades working with
the rural poor to scale up, has also benefited over 11 million people
in Africa in malaria control and another 37 million people from other
types of diseases.
Having worked within WHO/APOC management since its inception in
1996, Dr. Amazigo became the programme’s first female director in 2005
and steered it successfully for almost six years. She retired in April
2011, capping a long and distinguished career of service to poor
hard-to-reach African communities. During her leadership, the successes
of APOC’s operations saw the focus on the fight against Onchocerciasis
move from control to actual elimination of the disease with the
Onchocerciasis control programme widely recognized as being the most
successful and innovative public health campaign in the world.
A total of 75 medical personnel and scientists from 34 countries across
the world, were nominated this year for the Prince Mahidol Awards. Dr.
Amazigo, a recipient of the distinguished Medal of “Knight of the
National Order of Burkina Faso” in 2011, clinched the coveted prize in
the public health category, while Britain’s Sir Michael David Rawlins,
chairman of the National Institute for Health and Clinical Excellence
(NICE), is the winner in the field of medicine.
The Awards are given by the Thai Royal Family annually for
outstanding achievements in medicine and public health worldwide and
each awardee, receives a US$100,000 cash prize.
Typical of her modesty and unassuming character, Dr. Amazigo, says
she is humbled by the award, which she is receiving on behalf of African
communities, Merck & Co. Inc., for donating Ivermectin for the
treatment of River Blindness control for as long as needed, Governments,
APOC Management, WHO, World Bank, APOC donors, NGDOs, Research
Institutions, and her family.
“The money from the Award will be used to expand the philosophy of
CDI - community-directed school health and feeding programme in
resource-poor settings in Nigeria,” she affirmed.
Dr. Amazigo and Sir Michael will receive their awards at a ceremony in Thailand in January 2013.
Meanwhile, accolades have been pouring in congratulating and
celebrating Dr. Amazigo for her latest laurel, including from Nigeria’s
Health Minister, Prof. C.O. Onyebuchi Chukwu.
In its own reaction, the Washington D.C.-based Sabin Vaccine
Institute, a non-profit organization made up of scientists, researchers,
and advocates dedicated to reducing needless human suffering from
vaccine preventable and neglected tropical diseases, described Dr.
Amazigo as “a champion for NTD (Neglected Tropical Diseases) control and
elimination in Africa.”
Renowned Nigerian musician, Onyeka Onwenu, popularly called the
“Elegant Stallion,” a great admirer of Dr. Amazigo’s described the
awardee as “a magnificent human being; a humble innovator with a strong
passion and commitment to good causes.”
“I have travelled and worked with her on the field,” Onyeka said,
adding that the award was overdue for Dr. Amazigo’s exceptional
dedication to duty and service to humanity.
Only recently, Dr. Amazigo was honoured by the U.S. Agency for
International Development (USAID) and the National Medical Research
Institute of Tanzania for her immense contributions to public health
management, while WHO/APOC received the One-million-Euro António
Champalimaud Vision Award 2011, the biggest global award for outstanding
contributions to the prevention of visual impairment and blindness.
The Nigerian scientist is also presently lending her CDI expertise
to the Campaign by the Economic Community of West African States
(ECOWAS) to eliminate Malaria in the region by 2015 through an
integrated vector control strategy as happened with the successful River
Blindness control programme.
Dr. Amazigo received a Ph.D. in Biology and Medical Parasitology
from the University of Vienna in Austria. She also trained in Tropical
Medicine and Parasitology at the Bernhard-Nocht Institute of Tropical
Medicine in Hamburg, Germany, and got a Fellowship in International
Health from Harvard School of Public Health, U.S.A.
A member of the Consultative Group on Women's Health for the 1993
World Development Report, one eloquent testimony to Amazigo's
well-documented work in communication, advocacy, community mobilisation
and partnership is the UNFPA-UNIFEM-sponsored film "Broken Wings," which
she produced for the World Conference on Women in Beijing 1995. The
2005 nominee for the Global Champion of Health award by the US WGGH/NOVA
Science has also produced and edited several training modules on
engaging communities in healthcare delivery, with her works appearing in
international publications, including the medical health journal Lancet
and the Annals of Tropical Medicine and Parasitology.
Previous laureates of the Prince Mahidol Award include Professor
Frederick Sai of Ghana (1995), Alfred Sommer, a prominent American
ophthalmologist and professor of epidemiology recognized for his
pioneering work in vitamin A deficiency and pediatric mortality (1997),
Professor Satoshi Omura, Japan’s world leader in bio-organic chemistry
(1997), current WHO Director-General Dr. Margaret Chan of Hong Kong
(1998), as well as Nigeria’s internationally renowned public health
expert Professor Adetokunbo Lucas (1999).